logo

For the Inventor, By the Inventor

Skokie, IL, United States of America

Lifeng Geng

USPTO Granted Patents = 15

Average Co-Inventor Count = 13.4

ph-index = 8

Forward Citations = 304(Granted Patents)


Location History:

  • San Marcos, CA (US) (2006)
  • Skokie, IL (US) (1999 - 2007)

Company Filing History:

goldMedal8 out of 1,323 
 
G.d. Searle & Company
 patents
silverMedal7 out of 200 
 
Pharmacia Corporation
 patents

Years Active: 1999-2007

Loading Chart...
15 patents (USPTO):Explore Patents
1. 7186743 - Substituted pyrazolyl compounds for the treatment of inflammation (2007-03-06),
2. 7153959 - Substituted pyrazoles as p38 kinase inhibitors (2006-12-26),
3. 7071198 - Substituted pyrazoles as p38 kinase inhibitors (2006-07-04),
4. 7019005 - 3 (5)-heteroaryl substituted pyrazoles as p38 kinase inhibitors (2006-03-28),
5. 6979686 - Substituted pyrazoles as p38 kinase inhibitors (2005-12-27),
6. 6956052 - Substituted pyrazolyl compounds for the treatment of inflammation (2005-10-18),
7. 6849653 - Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation (2005-02-01),
8. 6617324 - Substituted pyrazoles as p38 kinase inhibitors (2003-09-09),
9. 6579873 - 3 (5)-heteroaryl substituted pyrazoles as p38 kinase inhibitors (2003-06-17),
10. 6525059 - Substituted pyrazoles as p38 kinase inhibitors (2003-02-25),
11. 6514977 - Substituted pyrazoles as p38 kinase inhibitors (2003-02-04),
12. 6423713 - Substituted pyrazoles as p38 kinase inhibitors (2002-07-23),
13. 6335336 - 3(5)-Heteroaryl substituted pyrazoles as p38 kinase inhibitors (2002-01-01),
14. 6087496 - Substituted pyrazoles suitable as p38 kinase inhibitors (2000-07-11),
15. 5932576 - 3(5)-heteroaryl substituted pyrazoles as p38 kinase inhibitors (1999-08-03),

Title: Lifeng Geng: Innovator in Pharmaceutical Chemistry

Introduction

Lifeng Geng is a prominent inventor based in Skokie, Illinois, known for his significant contributions to pharmaceutical chemistry. With a total of 15 patents to his name, Geng has made remarkable advancements in the treatment of various medical conditions, particularly inflammation and cancer.

Latest Patents

Among his latest patents, Geng has developed substituted pyrazolyl compounds aimed at treating inflammation. This invention encompasses substituted pyrazolyl derivatives, compositions that include these compounds, intermediates, and methods for their synthesis. Additionally, he has focused on methods for treating cancer and inflammation-associated disorders, such as arthritis. Another notable patent involves substituted pyrazoles as p38 kinase inhibitors, which are designed for use in treating disorders mediated by p38 kinase.

Career Highlights

Throughout his career, Lifeng Geng has worked with reputable companies, including G.D. Searle & Company and Pharmacia Corporation. His work in these organizations has contributed to the development of innovative pharmaceutical solutions.

Collaborations

Geng has collaborated with notable colleagues, including Michael John Clare and Gunnar J. Hanson, enhancing the impact of his research and inventions.

Conclusion

Lifeng Geng's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the field. His work continues to influence the development of treatments for critical health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…